Healthcare data firm IQVIA Q3 revenue beats on strong bookings
IQV•IQVIA’s Q3 revenue rose 8% to $4.43 billion, beating the $4.37 billion consensus, while adjusted diluted EPS increased 11% to $3.34, above the $3.28 estimate. The company raised its 2026 revenue guidance to $17.35 billion-$17.5 billion and lifted its adjusted EBITDA and adjusted EPS outlook.
1. Quarterly results
IQVIA reported Q3 revenue of $4.43 billion, up 8% and above analyst expectations of $4.37 billion. Adjusted diluted EPS rose 11% to $3.34, beating the $3.28 consensus; reported EPS was $2.10.
2. Bookings and outlook
R&D Solutions net new bookings rose 15% year over year to $3.2 billion, the company’s strongest clinical quarterly bookings since 2022. IQVIA said increased use of AI-powered solutions, including more than 400 deployed AI agents, contributed to organic growth acceleration. It raised its 2026 revenue outlook to $17.35 billion-$17.5 billion, adjusted EBITDA outlook to $4.025 billion-$4.055 billion, and adjusted diluted EPS outlook to $12.90-$13.00.
